nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A look into centrosome abnormalities in colon cancer cells, how they arise and how they might be targeted therapeutically
|
Harrison, Lauren E. |
|
2018 |
147 |
C |
p. 1-8 |
artikel |
2 |
A monoclonal antibody raised against a thermo-stabilised β1-adrenoceptor interacts with extracellular loop 2 and acts as a negative allosteric modulator of a sub-set of β1-adrenoceptors expressed in stable cell lines
|
Soave, Mark |
|
2018 |
147 |
C |
p. 38-54 |
artikel |
3 |
A partnership with the proteasome; the destructive nature of GSK3
|
Robertson, Holly |
|
2018 |
147 |
C |
p. 77-92 |
artikel |
4 |
Auxiliary subunits of AMPA receptors: The discovery of a forebrain-selective antagonist, LY3130481/CERC-611
|
Kato, Akihiko S. |
|
2018 |
147 |
C |
p. 191-200 |
artikel |
5 |
BAY 60–2770 activates two isoforms of nitric oxide sensitive guanylyl cyclase: Evidence for stable insertion of activator drugs
|
Sömmer, Anne |
|
2018 |
147 |
C |
p. 10-20 |
artikel |
6 |
BCRP/ABCG2 and high-alert medications: Biochemical, pharmacokinetic, pharmacogenetic, and clinical implications
|
Hira, Daiki |
|
2018 |
147 |
C |
p. 201-210 |
artikel |
7 |
Characterisation of endogenous A2A and A2B receptor-mediated cyclic AMP responses in HEK 293 cells using the GloSensor™ biosensor: Evidence for an allosteric mechanism of action for the A2B-selective antagonist PSB 603
|
Goulding, Joelle |
|
2018 |
147 |
C |
p. 55-66 |
artikel |
8 |
Corrigendum to “The external gate of the human and Drosophila serotonin transporters requires a basic/acidic amino acid pair for 3,4-methylenedioxymethamphetamine (MDMA) translocation and the induction of substrate efflux” [Biochem. Pharmacol. 120 (2016) 46–55]
|
Sealover, Natalie R. |
|
2018 |
147 |
C |
p. 9 |
artikel |
9 |
Differential effects of the Nrf2 activators tBHQ and CDDO-Im on the early events of T cell activation
|
Zagorski, Joseph W. |
|
2018 |
147 |
C |
p. 67-76 |
artikel |
10 |
Editorial Board
|
|
|
2018 |
147 |
C |
p. ii |
artikel |
11 |
Exogenous oxidants activate nuclear factor kappa B through Toll-like receptor 4 stimulation to maintain inflammatory phenotype in macrophage
|
Zhang, Yan |
|
2018 |
147 |
C |
p. 104-118 |
artikel |
12 |
FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models
|
Corno, Cristina |
|
2018 |
147 |
C |
p. 93-103 |
artikel |
13 |
Functional properties and mechanism of action of PPTQ, an allosteric agonist and low nanomolar positive allosteric modulator at GABAA receptors
|
Madjroh, Nawid |
|
2018 |
147 |
C |
p. 153-169 |
artikel |
14 |
HDAC inhibitor suppresses proliferation and invasion of breast cancer cells through regulation of miR-200c targeting CRKL
|
Bian, Xuehai |
|
2018 |
147 |
C |
p. 30-37 |
artikel |
15 |
How to effectively treat acute leukemia patients bearing MLL-rearrangements ?
|
Steinhilber, Dieter |
|
2018 |
147 |
C |
p. 183-190 |
artikel |
16 |
Modulating autophagy in cancer therapy: Advancements and challenges for cancer cell death sensitization
|
Bhat, Punya |
|
2018 |
147 |
C |
p. 170-182 |
artikel |
17 |
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction
|
Giorgio, Carmine |
|
2018 |
147 |
C |
p. 21-29 |
artikel |
18 |
Pharmacological targeting of exercise adaptations in skeletal muscle: Benefits and pitfalls
|
Weihrauch, Martin |
|
2018 |
147 |
C |
p. 211-220 |
artikel |
19 |
Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice
|
Neelakantan, Harshini |
|
2018 |
147 |
C |
p. 141-152 |
artikel |
20 |
Src family kinase tyrosine phosphorylates Toll-like receptor 4 to dissociate MyD88 and Mal/Tirap, suppressing LPS-induced inflammatory responses
|
Mitchell, Jonathon |
|
2018 |
147 |
C |
p. 119-127 |
artikel |
21 |
Targeting CXCR7 improves the efficacy of breast cancer patients with tamoxifen therapy
|
Hao, Mingang |
|
2018 |
147 |
C |
p. 128-140 |
artikel |